TrialSpark partners with Sanofi to acquire and develop clinical-stage novel therapies
TrialSpark has announced a new partnership with global pharma company Sanofi to explore novel methods…
October 4, 2022 - 2 minutes
Clinical trial
Aeglea BioTherapeutics updates homocystinuria program
Aeglea BioTherapeutics, Inc. says dosing in the third cohort of the phase 1/2 clinical trial…
October 4, 2022 - 3 minutes
HumanFirst launches industry’s largest decentralized clinical trial database
HumanFirst has launched two new versions of the Atlas platform designed specifically for researchers in…
October 4, 2022 - 2 minutes
FDA clears Kira Pharmaceuticals’ phase 2 trial for SLE-TMA treatment
Kira Pharmaceuticals says the US Food and Drug Administration (FDA) has cleared the investigational new…
October 3, 2022 - 3 minutes
Kling Biotherapeutics doses first patient in advanced solid tumor trial
Kling Biotherapeutics BV has dosed the first patient with KBA1412 in its phase 1b trial…
September 29, 2022 - 2 minutes
Positive results from study of drug to treat patients with breast cancer published
Results from a phase 1b study of a drug to treat patients with androgen receptor…
September 29, 2022 - 3 minutes
Treatment for adults with chronic skin condition approved by FDA
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of…
September 29, 2022 - 4 minutes
Positive results from Eisai and Biogen Alzheimer’s trial
Eisai Co., Ltd. and Biogen Inc. have announced positive topline results from Eisai’s large global…
September 29, 2022 - 6 minutes
Ilya Pharma enrols first patient in diabetic foot ulcer study
Ilya Pharma AB says the first patients have been enrolled in a phase II study…
September 28, 2022 - 2 minutes
Protocol for treatment of neurotrophic keratopathy submitted to FDA by ReGenTree
Protocol for a second phase 3 clinical trial for a treatment for neurotrophic keratopathy (NK)…
September 27, 2022 - 3 minutes
Bioheng Biotech has positive CAR-T cell therapy results published in academic journal
Positive results from a phase 1 clinical study of RD13-01, an anti-CD7 universal CAR-T therapy…
September 27, 2022 - 3 minutes
Angel Pharma announces approval of IND application for clinical trial of mupadolimab
Approval of an investigational new drug (IND) application for mupadolimab has been granted by the…
September 27, 2022 - 2 minutes
